United Therapeutics (UTHR) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $518.27 +1.93%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $1.34, $0.22 better than the analyst estimate of $1.12. Revenue for the quarter came in at $225.6 million versus the consensus estimate of $213.33 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Halozyme adds biotech executive Appelhans to its board
- La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
